Puma Biotechnology FDA Live Blog

A live blog of the FDA ' s deliberations on neratinib, a breast cancer drug developed by Puma Biotechnology.

Source: Forbes.com Healthcare News - May 24, 2017 Category: Pharmaceuticals Authors: Matthew Herper, Forbes Staff Tags: NASDAQ:PBYI Source Type: news